Back to search

United States· US:55910-870_4748e9cf-d844-a2e6-e063-6294a90ac4d4

DG Maximum Strength Redness Relief

A medicinal product containing glycerin; naphazoline hydrochloride, registered in United States by Dolgencorp, Inc.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDG Maximum Strength Redness ReliefATC—REGISTER NO.US:55910-870_4748e9cf…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
GLYCERIN; NAPHAZOLINE HYDROCHLORIDE
Manufacturer
Dolgencorp, Inc
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    55910-870-01
  • ndc11
    5591087001
    1 BOTTLE, DROPPER in 1 CARTON (55910-870-01) / 15 mL in 1 BOTTLE, DROPPER

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Glycerin; naphazoline hydrochloride in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glycerin; naphazoline hydrochloride products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e423af54-a74a-4ed9-807e-141665df7e5f
GET /v1/drugs/e423af54-a74a-4ed9-807e-141665df7e5f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "OPHTHALMIC",
  "source": "ndc",
  "strength": ".5; .03",
  "substance": "GLYCERIN; NAPHAZOLINE HYDROCHLORIDE",
  "productndc": "55910-870",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/100mL; g/100mL",
  "application_number": "M018",
  "marketing_category": "OTC MONOGRAPH DRUG"
}

See everything about glycerin; naphazoline hydrochloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.